ATE242765T1 - S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide als 5-ht2 rezeptor antagonist - Google Patents
S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide als 5-ht2 rezeptor antagonistInfo
- Publication number
- ATE242765T1 ATE242765T1 AT98903668T AT98903668T ATE242765T1 AT E242765 T1 ATE242765 T1 AT E242765T1 AT 98903668 T AT98903668 T AT 98903668T AT 98903668 T AT98903668 T AT 98903668T AT E242765 T1 ATE242765 T1 AT E242765T1
- Authority
- AT
- Austria
- Prior art keywords
- mpec
- cinnamanilide
- piperidyl
- ethyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/810,503 US5780487A (en) | 1995-08-07 | 1997-02-28 | S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide |
PCT/US1998/001304 WO1998038165A1 (en) | 1997-02-28 | 1998-01-23 | S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE242765T1 true ATE242765T1 (de) | 2003-06-15 |
Family
ID=25204013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98903668T ATE242765T1 (de) | 1997-02-28 | 1998-01-23 | S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide als 5-ht2 rezeptor antagonist |
Country Status (11)
Country | Link |
---|---|
US (1) | US5780487A (de) |
EP (1) | EP0973741B1 (de) |
JP (1) | JP3492378B2 (de) |
KR (1) | KR20000075696A (de) |
AT (1) | ATE242765T1 (de) |
AU (1) | AU750603B2 (de) |
CA (1) | CA2282840C (de) |
DE (1) | DE69815518T2 (de) |
ES (1) | ES2201440T3 (de) |
NO (1) | NO318443B1 (de) |
WO (1) | WO1998038165A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10036802A1 (de) * | 2000-07-28 | 2002-02-07 | Tesa Ag | Haftklebemassen auf Basis von Blockcopolymeren der Struktur P(A)-P(B)-P(A) |
MXPA04005427A (es) * | 2001-12-10 | 2005-04-19 | Amgen Inc | Ligandos de receptor vainilloide y su uso en tratamientos. |
AU2003263742A1 (en) * | 2002-06-13 | 2003-12-31 | Cummins-Allison Corp. | Currency processing and strapping systems and methods for using the same |
DE10358525A1 (de) | 2003-12-13 | 2005-07-07 | Bayer Healthcare Ag | Endoparasitizide Mittel zur topischen Applikation |
KR20080070745A (ko) * | 2005-11-17 | 2008-07-30 | 노파르티스 아게 | 유기 화합물 |
BRPI0618790A2 (pt) * | 2005-11-17 | 2011-09-13 | Novartis Ag | compostos orgánicos |
CA2739489A1 (en) * | 2008-10-22 | 2010-04-29 | Sam Amer & Co., Inc. | Method for treating pulmonary arterial hypertension |
WO2012026914A1 (en) * | 2010-08-23 | 2012-03-01 | Sam Amer & Co., Inc. | Methods and compositions for treating internal and external hemorrhoids |
WO2013070236A1 (en) * | 2011-11-11 | 2013-05-16 | Ventrus Biosciences, Inc. | Methods and compositions for treating hemorrhoids while providing local anesthetic and anti-inflammatory effects |
CN102924374B (zh) * | 2012-02-15 | 2014-04-16 | 湖北欣瑞康医药科技有限公司 | 喹啉-4-羧酸衍生物的制备方法 |
CH706161A1 (de) | 2012-03-15 | 2013-10-15 | Oti Greentech Group Ag | Ölrückgewinnung. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000143A (en) * | 1971-03-03 | 1976-12-28 | Mead Johnson & Company | Substituted piperidines |
US4064254A (en) * | 1971-03-03 | 1977-12-20 | Mead Johnson & Company | Substituted piperidines therapeutic process and compositions |
US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
GB9402688D0 (en) * | 1994-02-11 | 1994-04-06 | Merck Sharp & Dohme | Therapeutic agents |
-
1997
- 1997-02-28 US US08/810,503 patent/US5780487A/en not_active Expired - Lifetime
-
1998
- 1998-01-23 CA CA002282840A patent/CA2282840C/en not_active Expired - Fee Related
- 1998-01-23 AU AU60377/98A patent/AU750603B2/en not_active Ceased
- 1998-01-23 ES ES98903668T patent/ES2201440T3/es not_active Expired - Lifetime
- 1998-01-23 JP JP52083598A patent/JP3492378B2/ja not_active Expired - Fee Related
- 1998-01-23 EP EP98903668A patent/EP0973741B1/de not_active Expired - Lifetime
- 1998-01-23 AT AT98903668T patent/ATE242765T1/de not_active IP Right Cessation
- 1998-01-23 DE DE69815518T patent/DE69815518T2/de not_active Expired - Lifetime
- 1998-01-23 KR KR1019997007763A patent/KR20000075696A/ko not_active Application Discontinuation
- 1998-01-23 WO PCT/US1998/001304 patent/WO1998038165A1/en not_active Application Discontinuation
-
1999
- 1999-08-27 NO NO19994181A patent/NO318443B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO994181D0 (no) | 1999-08-27 |
CA2282840C (en) | 2006-04-11 |
EP0973741B1 (de) | 2003-06-11 |
DE69815518D1 (en) | 2003-07-17 |
DE69815518T2 (de) | 2004-04-22 |
ES2201440T3 (es) | 2004-03-16 |
NO994181L (no) | 1999-10-27 |
AU750603B2 (en) | 2002-07-25 |
WO1998038165A1 (en) | 1998-09-03 |
CA2282840A1 (en) | 1998-09-03 |
EP0973741A1 (de) | 2000-01-26 |
JP2001527521A (ja) | 2001-12-25 |
JP3492378B2 (ja) | 2004-02-03 |
NO318443B1 (no) | 2005-03-21 |
US5780487A (en) | 1998-07-14 |
AU6037798A (en) | 1998-09-18 |
KR20000075696A (ko) | 2000-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE242765T1 (de) | S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide als 5-ht2 rezeptor antagonist | |
NO950774L (no) | Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol | |
DK0735868T3 (da) | Anvendelse af ikke-steroide cyclooxygenaseinhibitorer til fremstilling af et medikament til behandling af forhøjet intrakul | |
GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
SE9503924D0 (sv) | Novel opioid peptides | |
NO981528D0 (no) | Substituerte imidazoler med antikreft- og cytokininhibitoraktivitet | |
ES2089665T3 (es) | Terazosina polimorfa y composicion farmaceutica. | |
GT199700037A (es) | Composiciones farmaceuticas para el tratamiento de la rinitis | |
ES2102994T3 (es) | Derivados de benzisotiazolinona-1-dioxido como inhibidores de elastasa. | |
IL111127A (en) | Short-acting calcium antagonist dihydropyridines process for their preparation and pharmaceutical compositions containing them | |
BR0013935A (pt) | IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos | |
IT1250049B (it) | Composti triciclici. | |
RU94046107A (ru) | Замещенные производные 2 бета - морфолинандростана, способ их получения, фармакомпозиция, содержащая их | |
TR200200263T2 (tr) | Yeni seçiçi retinoid agonistleri | |
MY111055A (en) | Pharmaceutical composition and process for the preparation thereof | |
GEP20012389B (en) | Benzoxazinone Dopamine D4 Receptor Antagonists, Pharmaceutical Composition Containing the Same and Method for Treatment of Psychosis or Schizophrenia | |
ES2106531T3 (es) | Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso. | |
KR910018020A (ko) | 프라바스타틴과 피브르산 유도체의 혼합제. 및 이 혼합제를 사용한 이상지혈증 치료 방법 | |
EA199800013A1 (ru) | Способы минимизации остеопороза | |
KR960700696A (ko) | 정맥성 질환 치료에 유용한 5-하이드록시트립타민-2 수용체 길항물질 조성물(5-ht₂receptor antagonist compositions useful in treating venous conditions) | |
AU3623399A (en) | Use of benzofuroxan derivatives in treating angina pectoris | |
ECSP941088A (es) | Composiciones | |
DE69414396D1 (de) | Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten | |
TR200000154T2 (tr) | 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler. | |
FI950209A0 (fi) | Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |